Author Correction: Circularly Permuted and PAM-modified Cas9 Variants Broaden the Targeting Scope of Base Editors
Overview
Authors
Affiliations
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
CRISPR/Cas9 therapeutics: progress and prospects.
Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X Signal Transduct Target Ther. 2023; 8(1):36.
PMID: 36646687 PMC: 9841506. DOI: 10.1038/s41392-023-01309-7.
MagnEdit-interacting factors that recruit DNA-editing enzymes to single base targets.
McCann J, Salamango D, Law E, Brown W, Harris R Life Sci Alliance. 2020; 3(4).
PMID: 32094150 PMC: 7043409. DOI: 10.26508/lsa.201900606.
Wang Y, Zhou L, Liu N, Yao S Signal Transduct Target Ther. 2019; 4:36.
PMID: 31637015 PMC: 6799832. DOI: 10.1038/s41392-019-0072-7.